Gleason Group Inc. acquired a new stake in Colgate-Palmolive (NYSE:CL – Get Rating) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 4,000 shares of the company’s stock, valued at approximately $315,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Accurate Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the fourth quarter worth approximately $27,000. Hallmark Capital Management Inc. grew its stake in shares of Colgate-Palmolive by 158.2% in the third quarter. Hallmark Capital Management Inc. now owns 408 shares of the company’s stock worth $29,000 after purchasing an additional 250 shares in the last quarter. EdgeRock Capital LLC acquired a new position in shares of Colgate-Palmolive during the third quarter valued at $35,000. Norway Savings Bank raised its stake in shares of Colgate-Palmolive by 57.8% during the third quarter. Norway Savings Bank now owns 546 shares of the company’s stock valued at $38,000 after purchasing an additional 200 shares in the last quarter. Finally, McClarren Financial Advisors Inc. acquired a new stake in Colgate-Palmolive in the third quarter worth about $42,000. Institutional investors own 77.63% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have commented on CL shares. Barclays dropped their price target on shares of Colgate-Palmolive from $80.00 to $77.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 31st. TheStreet lowered Colgate-Palmolive from a “b” rating to a “c+” rating in a research note on Friday, January 27th. JPMorgan Chase & Co. boosted their price objective on Colgate-Palmolive from $81.00 to $86.00 and gave the stock an “overweight” rating in a research note on Friday, January 13th. StockNews.com began coverage on Colgate-Palmolive in a research note on Thursday. They set a “hold” rating for the company. Finally, Citigroup assumed coverage on shares of Colgate-Palmolive in a research report on Thursday, February 16th. They issued a “buy” rating and a $84.00 price target on the stock. Six analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $82.09.
Colgate-Palmolive Stock Down 1.0 %
Colgate-Palmolive (NYSE:CL – Get Rating) last announced its earnings results on Friday, January 27th. The company reported $0.77 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.77. The company had revenue of $4.63 billion for the quarter, compared to the consensus estimate of $4.58 billion. Colgate-Palmolive had a net margin of 9.93% and a return on equity of 317.08%. The company’s revenue was up 5.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.79 EPS. As a group, equities research analysts anticipate that Colgate-Palmolive will post 3.1 EPS for the current year.
Colgate-Palmolive Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, May 15th. Investors of record on Friday, April 21st will be issued a dividend of $0.48 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.47. This represents a $1.92 annualized dividend and a dividend yield of 2.66%. The ex-dividend date is Thursday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 88.26%.
Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through the Oral, Personal and Home Care, and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.
- Get a free copy of the StockNews.com research report on Colgate-Palmolive (CL)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.